Formula: | C19H16FN5O |
Molecular Weight: | 349.37 |
Rotatable Bond Donors: | 3 |
clogP: | 2.90 |
Topological Polar Surface Area: | 63.91 |
Lipinski's RO5: | MW: 349.37 HBA: 6 HBD: 0 RB: 3 LogP: 2.90 |
Rule of Three: | MW: 349.37 HBA: 6 HBD: 0 RB: 3 LogP: 2.90 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC13983188 | 1.0 | ZINC13983188 RDKit 3D 26 30 0 0 0 0 0 0 0 0999 V2000 1.4830 1.4260 0.8107 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8076 0.0928 0.2759 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9702 -0.9465 -0.0885 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4790 -0.9670 -0.1048 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1377 -2.1734 -0.4248 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5295 -2.2664 -0.4658 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2314 -1.1144 -0.1824 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6093 0.0898 0.1370 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2324 0.1794 0.1789 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6292 1.1470 0.4005 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8673 0.4353 0.1578 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.1209 1.0255 0.4492 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.5083 2.3785 -0.0732 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.1989 1.1534 -0.5879 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6805 -0.9050 -0.1389 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.5139 -1.7705 -0.3196 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7222 -2.0324 -0.4247 N 0 0 0 0 0 0 0 0 0 0 0 0 2.9963 -1.7134 -0.2820 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0896 -0.4083 0.0875 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3716 0.1613 0.2277 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4738 -0.6966 0.1989 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7645 -0.2069 0.3427 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9064 1.1572 0.5056 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8728 2.0257 0.5163 N 0 0 0 0 0 0 0 0 0 0 0 0 4.6300 1.5103 0.3693 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6503 2.4187 0.3022 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 2 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 2 0 8 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 11 15 1 0 15 16 2 0 3 17 1 0 17 18 2 0 18 19 1 0 19 20 1 0 20 21 2 0 21 22 1 0 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 19 2 1 0 25 20 1 0 9 4 1 0 14 12 1 0 15 7 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |